3D-printed Reconstruction Automated Matching System Predicts Size of Double-lumen Tube: a Prospective Double-blinded Randomized Controlled Trial
Effect of 3D-printed Reconstruction Automated Matching System in Size Selection of Double-lumen Tube:a Prospective Double-blinded Randomised Controlled Trial
1 other identifier
interventional
200
0 countries
N/A
Brief Summary
Lung isolation techniques are commonly used to facilitate surgical exposure and to provide single-lung ventilation for patients. We have developed an automatic comparison software for 3D reconstruction based on CT data (3DRACS). It reconstructs the trachea and bronchus and compares them with the DLT, predicting the most suitable size and depth of the DLT for lung isolation.The aim of this study was to compare whether the use of 3DRACS to select a DLT size compared to conventional empirical selection methods could improve incidence of DLT intubation success and reduce airway injury.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable lung-cancer
Started Nov 2023
Shorter than P25 for not_applicable lung-cancer
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 17, 2023
CompletedFirst Posted
Study publicly available on registry
June 12, 2023
CompletedStudy Start
First participant enrolled
November 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
March 30, 2024
CompletedJune 12, 2023
June 1, 2023
29 days
May 17, 2023
June 2, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Incidence of correct endobronchial intubation.
Conventional blindly endobronchial intubation is performed firstly and clinical verification was made by the same anesthesiologist, followed by the supervising anesthesiologist using a FOB to check DLT position and successful intubation was considered if the position was proper.
after intubation
Secondary Outcomes (6)
Time to successful intubation
after intubation
Degree of pulmonary atrophy
after surgery begin
Grading of airway injury
When extubation
Postoperative sore throat and hoarseness
At 1 hour and 24 hours after extubation
Oxygenation during one-lung ventilation
Intraoperative(from beginning of one lung ventilation to end),an average of 2 hours
- +1 more secondary outcomes
Study Arms (2)
3D group
EXPERIMENTALIn 3D group, the investigator will intubate using DLT chosen by an automatic comparison software for 3D reconstruction based on CT data (3DRACS).
control group
PLACEBO COMPARATORIn control group, the size of DLT is based on patient's sex and weight and the height is used to guide the depth of DLT insertion.
Interventions
it is an automatic comparison software for 3D reconstruction based on CT data (3DRACS). It reconstructs the trachea and bronchus and compares them with the DLT, predicting the most suitable size and depth of the DLT for lung isolation.
In control group, the size of DLT is based on patient's sex and weight and the height is used to guide the depth of DLT insertion.
Eligibility Criteria
You may qualify if:
- Aged between 18 and 75 years.
- American Society of Anesthesiologists Physical Status (ASA-PS) I-III.
- Planned to receive lung resection surgery during lung isolation techniques by using DLT.
- Signed informed written consent.
You may not qualify if:
- The participant experiences any of the following:
- Spinal malformation,
- Expected difficult airway
- Tracheal stenosis
- Tracheal tumor
- Bronchial tumor
- Distorted airway anatomy
- Tumors of the mouth or neck
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Yihao Zhu, master
department of anesthesiology, sichuan cancer hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Two investigators performing intubation of DLT will be blinded to the intervention. All participates and researchers responsible for surgery, bronchoscopy assessment, follow-up, data management and analysis will also be blinded to the grouping.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Professor
Study Record Dates
First Submitted
May 17, 2023
First Posted
June 12, 2023
Study Start
November 1, 2023
Primary Completion
November 30, 2023
Study Completion
March 30, 2024
Last Updated
June 12, 2023
Record last verified: 2023-06
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- The raw data are available from the corresponding author with applicable reason after publishing findings to a peer-reviewed journal.
Data are available on reasonable request. The raw data are available from the corresponding author with applicable reason after publishing findings to a peer-reviewed journal.